Subscribe
Sign in
Stop Calling GLP-1s a Trend
Ashwin Sharma, MD
May 18
5
1
83 % refills, $2.2 B pill deals, Saudi production lines. The fad died; the utility was born.
Read →
Comments
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Stop Calling GLP-1s a Trend
83 % refills, $2.2 B pill deals, Saudi production lines. The fad died; the utility was born.